Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation - In asthma, the airways become inflamed due to an exaggerated response to allergens or irritants, leading to swelling and increased mucus production. This inflammation is driven by immune cells, particularly eosinophils and T-helper 2 cells, which release cytokines that sustain the inflammatory response.

• Secondary mechanism: Bronchoconstriction - In response to inflammation, the smooth muscles surrounding the airways constrict, narrowing the airways and causing difficulty in breathing. This bronchoconstriction is often triggered by exposure to allergens, cold air, or exercise.

• Key complication: Airway remodeling - Chronic inflammation and repeated episodes of asthma exacerbate structural changes in the airway, such as thickening of the airway wall and increased mucus gland size, which can lead to persistent airflow obstruction and reduced lung function over time.

Patient Profile

Demographics:

35-year-old female, school teacher

History:

• Key past medical history: Diagnosed with asthma at age 12, seasonal allergies, occasional GERD

• Current medications: Albuterol inhaler PRN, Fluticasone inhaler BID, Montelukast 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, fatigue, occasional night awakenings due to breathing difficulties

• Vital signs: Blood pressure 138/86 mmHg, heart rate 104 bpm, respiratory rate 24 breaths per minute, temperature 98.7°F, oxygen saturation 91% on room air

Section 1

Change in Patient Status:

Over the next 24 hours, the patient's condition began to show signs of deterioration. Despite adhering to her prescribed medication regimen, her shortness of breath and wheezing intensified, prompting a reevaluation of her current management plan. The patient reported increased frequency of nighttime awakenings due to breathlessness, and she experienced a notable decrease in her ability to perform daily activities, such as teaching, without experiencing significant fatigue and breathlessness.

A repeat assessment revealed concerning changes in her vital signs: her respiratory rate had increased to 28 breaths per minute, and her oxygen saturation dropped further to 88% on room air, indicating a possible progression towards respiratory distress. Auscultation of the lungs revealed diffuse bilateral wheezing, more pronounced than previously noted, and diminished breath sounds in the lower lobes, suggesting worsening airway obstruction. The patient exhibited accessory muscle use and nasal flaring, both signs of increased respiratory effort.

These clinical changes necessitated further investigation and a more aggressive management approach to prevent further decline. The healthcare team decided to initiate supplemental oxygen therapy to maintain adequate oxygenation and considered adjusting her medication regimen to include a short course of oral corticosteroids to address the underlying inflammation more effectively. Additionally, the possibility of initiating a referral to a pulmonologist for further evaluation and management of potential long-term complications, such as airway remodeling, was discussed. This change in her clinical status highlighted the need for timely intervention to prevent progression to a more severe asthma exacerbation and potential complications such as respiratory failure.

Section 2

Response to Interventions:

Following the initiation of supplemental oxygen therapy at 2 liters per minute via nasal cannula, the patient's oxygen saturation improved to 92%, providing some relief from the hypoxemia. However, her respiratory rate remained elevated at 26 breaths per minute, and she continued to experience significant dyspnea. The healthcare team decided to initiate a short course of oral corticosteroids, prednisone 40 mg daily for five days, in an attempt to quickly reduce airway inflammation and stabilize her condition. Bronchodilator therapy was intensified, with the addition of nebulized albuterol treatments every four hours.

After 12 hours of this more aggressive management, the patient began to show some improvement. Her wheezing decreased slightly, and the use of accessory muscles became less pronounced, indicating a partial response to the interventions. However, she continued to report fatigue and difficulty with exertional activities, such as walking short distances or climbing stairs. A follow-up assessment revealed that while her breath sounds had improved, the lower lobes still exhibited diminished airflow, pointing to persistent obstruction.

The patient's partial response to the interventions prompted the healthcare team to reconvene and discuss the next steps. Consideration was given to conducting additional diagnostic tests, such as a repeat chest X-ray and pulmonary function tests, to further assess the severity of her airway obstruction and to rule out other potential complications, such as an underlying infection or developing atelectasis. The team also decided to expedite the referral to a pulmonologist to provide specialized care and to explore potential long-term management strategies, including the possibility of adjusting her long-term asthma control medications to prevent future exacerbations. The patient's condition underscored the need for ongoing monitoring and a comprehensive management plan to avert further deterioration and enhance her quality of life.

Section 3

New Diagnostic Results:

As the healthcare team proceeded with further diagnostic testing, a repeat chest X-ray was conducted alongside pulmonary function tests. The chest X-ray revealed mild bilateral atelectasis, particularly in the lower lobes, which correlated with the diminished airflow noted during the physical examination. This finding suggested that, despite the initial improvements, the patient was not yet fully ventilating all areas of her lungs, leading to persistent dyspnea and reduced exercise tolerance. The pulmonary function tests indicated a significant reduction in her FEV1 (Forced Expiratory Volume in 1 second), which measured at 60% of the predicted value, confirming moderate airway obstruction. These results were consistent with her known asthma but raised concerns about the possibility of additional factors contributing to her current exacerbation.

Given these findings, the team acknowledged the need to address the atelectasis aggressively while continuing her current asthma management. A regimen of chest physiotherapy, including incentive spirometry, was introduced to promote lung expansion and facilitate mucous clearance. The possibility of an underlying infection was also considered; thus, a complete blood count (CBC) was performed, revealing a slight elevation in white blood cell count, which warranted close monitoring and potential empirical antibiotic therapy if clinical suspicion increased.

The team recognized that while the immediate focus was on resolving the current exacerbation, there was also a need to refine her long-term management strategy. The referral to a pulmonologist was prioritized to evaluate the potential role of inhaled corticosteroids or long-acting bronchodilators in her maintenance therapy. The objective was to prevent future exacerbations and improve her overall pulmonary function. The healthcare team planned a multidisciplinary meeting to discuss these results with the patient, emphasizing the importance of adherence to the treatment plan and understanding her role in managing her asthma effectively. This approach aimed to empower the patient, reduce the risk of further complications, and enhance her quality of life.

Section 4

Change in Patient Status:

Over the following 48 hours, the patient experienced a noticeable change in her clinical status. Despite the implementation of chest physiotherapy and the use of incentive spirometry, her dyspnea persisted, and she began to exhibit increased respiratory effort. On reassessment, her vital signs showed a respiratory rate of 28 breaths per minute, heart rate of 110 beats per minute, and oxygen saturation of 92% on room air, indicating a decline in her respiratory status. Auscultation revealed diffuse wheezing and diminished breath sounds in the lower lobes, consistent with her previous diagnostic findings of atelectasis. The patient also reported a new onset of productive cough with yellowish sputum, raising the suspicion of infection.

Given these developments, the healthcare team decided to initiate empirical antibiotic therapy to address the potential underlying infection, which was supported by the earlier slight elevation in white blood cell count. A sputum culture was obtained to guide targeted antibiotic therapy. The patient's bronchodilator regimen was also intensified, adding a long-acting beta-agonist to her treatment plan to alleviate airway obstruction and improve her breathing. The team carefully monitored her response, noting any changes in sputum characteristics and adjusting treatment accordingly.

This change in patient status prompted the healthcare team to consider additional potential complications, such as pneumonia or an impending respiratory failure due to the unresolved atelectasis and ongoing airway obstruction. The patient was closely monitored for any signs of deterioration, and plans for potential escalation of care, including possible admission to a higher level of care, were discussed. This situation underscored the importance of a coordinated, multidisciplinary approach to her management, emphasizing the need for continuous reassessment and prompt intervention to prevent further complications.

Section 5

The patient's response to the intensified treatment regimen was initially encouraging, as her respiratory rate slightly decreased to 24 breaths per minute, and her oxygen saturation improved to 94% on 2 liters of supplemental oxygen via nasal cannula. However, over the next 24 hours, she developed a low-grade fever of 100.8°F and her cough became more frequent and productive, with sputum changing to a greenish color. A repeat auscultation revealed coarse crackles in addition to the diffuse wheezing, suggesting the development of an additional respiratory complication.

The results of the sputum culture and sensitivity test confirmed the presence of a bacterial infection, specifically Streptococcus pneumoniae, correlating with the clinical suspicion of pneumonia. This finding prompted a timely adjustment in her antibiotic therapy to a more targeted regimen, including ceftriaxone, to effectively combat the identified pathogen. Concurrently, a chest X-ray was ordered and revealed consolidation in the right lower lobe, further substantiating the diagnosis of pneumonia alongside her existing atelectasis.

The healthcare team recognized the patient's situation as a complex interplay of unresolved asthma exacerbation and superimposed pneumonia, necessitating vigilant monitoring and holistic management. They emphasized the importance of optimizing her bronchodilator therapy and ensuring adequate hydration to assist in mucociliary clearance. The team also prepared for potential escalation in care, with the possibility of non-invasive ventilation if her respiratory effort continued to increase. This evolving scenario highlighted the critical need for ongoing clinical reasoning, with a focus on preventing respiratory failure and guiding the patient back to stability.